ETV1 genetic polymorphisms as a candidate prognosis biomarker of Gastrointestinal stromal tumor
Cancer Chemotherapy and Pharmacology · 2025
DOI: 10.1007/s00280-025-04789-2 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cancer Chemotherapy and Pharmacology, 2025. Verfasst von Wei Zhuang und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacy, Women and Children's Hospital, School of Medicine, Xiamen University, Xiamen, P.R. China. Hauptthemen laut MEDLINE: Gastrointestinal Stromal Tumors, Polymorphism, Single Nucleotide, Biomarkers, Tumor, Transcription Factors. Die Arbeit nennt 41 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Natural Science Foundation of Xiamen Municipality, Natural Science Foundation of Fujian Province.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pharmacy, Women and Children's Hospital, School of Medicine, Xiamen University, Xiamen, P.R. China.
- Institute of Clinical Pharmacology, School of Pharmaceutical Sciences, Sun Yat-Sen University, Guangzhou, P.R. China.
- Department of Gastric Surgery, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-Sen University Cancer Center, Guangzhou, P.R. China.
- Institute of Clinical Pharmacology, School of Pharmaceutical Sciences, Sun Yat-Sen University, Guangzhou, P.R. China. huangmin@mail.sysu.edu.cn.
- Institute of Clinical Pharmacology, School of Pharmaceutical Sciences, Sun Yat-Sen University, Guangzhou, P.R. China. wangxd@mail.sysu.edu.cn.
Förderung
- National Natural Science Foundation of China
- Natural Science Foundation of Xiamen Municipality
- Natural Science Foundation of Fujian Province
- Young and Middle-aged Talent Cultivation Projects of Xiamen
- Guangdong Provincial Key Laboratory of Construction Foundation
Zitieren
APA
Zhuang, W., Jo, M., Qiu, H., Lin, W., Huang, M., & Wang, X. (2025). ETV1 genetic polymorphisms as a candidate prognosis biomarker of Gastrointestinal stromal tumor. Cancer Chemotherapy and Pharmacology. https://doi.org/10.1007/s00280-025-04789-2
Vancouver
Zhuang W, Jo M, Qiu H, Lin W, Huang M, Wang X. ETV1 genetic polymorphisms as a candidate prognosis biomarker of Gastrointestinal stromal tumor. Cancer Chemotherapy and Pharmacology. 2025. doi:10.1007/s00280-025-04789-2
BibTeX
@article{Zhuang2025,
author = {Zhuang, Wei and Jo, Minju and Qiu, Haibo and Lin, Wanlong and Huang, Min and Wang, Xueding},
title = {ETV1 genetic polymorphisms as a candidate prognosis biomarker of Gastrointestinal stromal tumor},
journal = {Cancer Chemotherapy and Pharmacology},
year = {2025},
doi = {10.1007/s00280-025-04789-2}
}
EUVIMED